VERVE THERAPEUTICS INC. - COMMON STOCK
6.2600
13-March-25 10:31:54
15 minutes delayed
Stocks
-0.1600
-2.49%
Today's range
6.2400 - 6.5900
ISIN
N/A
Source
NASDAQ
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Mar 2025 16:05:00 By Nasdaq GlobeNewswire
-
27 Feb 2025 07:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Feb 2025 16:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
29 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
13 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
08 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Jan 2025 16:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
29 Nov 2024 16:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
05 Nov 2024 07:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2024 16:26:49 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 Oct 2024 16:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Sep 2024 16:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
08 Aug 2024 07:00:01 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 Aug 2024 16:05:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
28 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
31 May 2024 16:01:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Leadership Update
31 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics to Participate in Upcoming Investor Conferences
30 May 2024 16:01:00 By Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
08 May 2024 07:00:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >